Live Interactive Webinar Series
Live, interactive, case based discussions - free CME and Nursing Continuing Education Units
Dates:
- Session 1: ECHO Overview + Multiple Myeloma – August 19, 2026, 4:00pm – 5:00pm ET
- Session 2: Chronic Lymphocytic Leukemia – September 23, 2026, 1:00pm – 2:00pm ET
- Session 3: Myelodysplastic Syndromes / Acute Myeloid Leukemia – October 21, 2026, 4:00pm – 5:00pm ET
- Session 4: Non-Hodgkin Lymphoma – November 16, 2026, 1:00pm – 2:00pm ET
- Session 5: Acute Lymphoblastic Leukemia – December 2, 2026, 4:00pm – 5:00pm ET
- Session 6: Post-Transplant / Post-CAR T-Cell Therapy – January 25, 2027, 1:00pm – 2:00pm ET
Target Audience
Community cancer program clinicians and multidisciplinary oncology care teams, including physicians, advanced practice providers, nurses, navigators, and psychosocial professionals.
Faculty
Jane Dabney, LISW-S, OSW-C
Social Worker, Blood & Marrow Transplant (BMT) Program
The Cleveland Clinic Foundation
Cleveland, OH
Harold Dean, LCSW, OSW-C, FAOSW
Clinical Social Work Program Manager
University of Arkansas for Medical Sciences Myeloma Center
Little Rock, AR
Joanne E. Filicko-O'Hara, MD
Associate Program Director, Combined Fellowship in Hematology/Medical Oncology
Professor
Thomas Jefferson University
Philadelphia, PA
Thomas William LeBlanc, MD, MA, MHS, FAAHPM, FASCO
Associate Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Duke University School of Medicine
Durham, NC
Jonathan Moreira, MD
Associate Professor of Medicine in the Department of Medicine
Division of Hematology/Oncology
Northwestern University’s Feinberg School of Medicine
Chicago, IL
Continuing Education Information
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Pediatrics (AAP) and the American Cancer Society. The American Academy of Pediatrics is accredited by the ACCME to provide continuing medical education for physicians.
AAP designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is acceptable for a maximum of 5.0 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
PAs may claim a maximum of 5.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)TM from organizations accredited by the ACCME or a recognized state medical society.
This program is accredited for 5.0 NAPNAP CE contact hours of which 0 hrs contain pharmacology (Rx) content, (0 related to psychopharmacology) (0 hours related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.
This Provider approved by the California Board of Registered Nursing, Provider Number 18014, for 5.0 contact hours.
Providers
This activity is provided by Blood Cancer United, NMDP, and American Cancer Society.
Supporters
There is no commercial support associated with this activity.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at [email protected].